Portside Wealth Group LLC increased its position in shares of CVS Health Co. (NYSE:CVS - Free Report) by 14.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 30,835 shares of the pharmacy operator's stock after acquiring an additional 3,956 shares during the period. Portside Wealth Group LLC's holdings in CVS Health were worth $2,089,000 at the end of the most recent quarter.
A number of other hedge funds have also recently bought and sold shares of CVS. Stonebridge Financial Group LLC purchased a new position in CVS Health in the 4th quarter worth about $28,000. Hopwood Financial Services Inc. acquired a new stake in shares of CVS Health during the 4th quarter valued at about $29,000. McIlrath & Eck LLC lifted its holdings in shares of CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after buying an additional 174 shares during the last quarter. Financial Perspectives Inc lifted its holdings in shares of CVS Health by 137.5% during the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after buying an additional 466 shares during the last quarter. Finally, MidAtlantic Capital Management Inc. lifted its holdings in shares of CVS Health by 112.1% during the 4th quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator's stock valued at $37,000 after buying an additional 437 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.
CVS Health Price Performance
Shares of CVS stock opened at $63.61 on Monday. The stock's fifty day simple moving average is $65.21 and its 200 day simple moving average is $59.94. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The firm has a market cap of $80.47 billion, a price-to-earnings ratio of 17.38, a P/E/G ratio of 0.98 and a beta of 0.56. CVS Health Co. has a one year low of $43.56 and a one year high of $72.51.
CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating the consensus estimate of $1.62 by $0.63. The business had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. CVS Health's quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.31 EPS. On average, analysts expect that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.
CVS Health Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.18%. The ex-dividend date was Tuesday, April 22nd. CVS Health's dividend payout ratio is 63.48%.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on the company. Cantor Fitzgerald raised CVS Health from a "neutral" rating to an "overweight" rating in a research note on Wednesday, February 12th. Barclays set a $79.00 price objective on CVS Health and gave the company an "overweight" rating in a research note on Monday, June 2nd. Leerink Partners raised CVS Health from a "market perform" rating to an "outperform" rating and raised their price objective for the company from $55.00 to $75.00 in a research note on Thursday, February 13th. Morgan Stanley reissued an "overweight" rating on shares of CVS Health in a research note on Tuesday, April 15th. Finally, Cowen reaffirmed a "buy" rating on shares of CVS Health in a research report on Monday, May 5th. Two research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $74.75.
Read Our Latest Stock Report on CVS Health
CVS Health Profile
(
Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
